Jack A. Khattar - May 11, 2023 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Signature
/s/ Timothy C. Dec, as attorney-in-fact
Stock symbol
SUPN
Transactions as of
May 11, 2023
Transactions value $
-$547,232
Form type
4
Date filed
5/12/2023, 05:00 PM
Previous filing
May 8, 2023
Next filing
Jun 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Options Exercise $0 +31.3K +3.75% $0.00 864K May 11, 2023 Direct F1
transaction SUPN Common Stock Tax liability -$547K -15K -1.74% $36.47 849K May 11, 2023 Direct F2
holding SUPN Common Stock 1.04M May 11, 2023 By the KBT Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Performance Share Unit Options Exercise $0 -31.3K -100% $0.00* 0 May 11, 2023 Common Stock 31.3K $0.00 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of common stock received upon the settlement of certain performance share units granted to the Reporting person on May 3, 2022.
F2 Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the PSU vesting.
F3 On May 3, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period.